Replies to post #4160 on Quanta Inc (fka QNTA)

[~MulaGreen~]

Medolife is conducting clinical trials on Escozine(R) as a treatment for COVID-19 in both the United States and the DR.

The Company has completed an Investigational New Drug (IND) filing on Escozine(R) through the US Food and Drug Administration (FDA) and is awaiting a response after submission of its final data set.

Escozine(R) recently received renewed product registration in the DR, enabling it to be sold as a natural alternative medicine for the treatment of cancer throughout Latin America.